Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma
Christopher J. Gibson(Otsuka (Japan)), Benjamin L. Ebert(Dana-Farber Cancer Institute), Jerome Ritz(Dana-Farber Cancer Institute), Ravi Bhatia(University of Alabama at Birmingham), Vatche Tchekmedyian(Otsuka (Japan)), Elizabeth A. Morgan(Brigham and Women's Hospital), Brenton G. Mar(Otsuka (Japan)), John Koreth(Otsuka (Japan)), Vincent T. Ho(Dana-Farber Cancer Institute), Liton Francisco(City Of Hope National Medical Center), Arnold S. Freedman(Otsuka (Japan)), Alysia Bosworth(Otsuka (Japan)), Stephen J. Forman(City Of Hope National Medical Center), Jiantao Shi(Chinese Academy of Sciences), Anita Bansal(Otsuka (Japan)), Philippe Armand(Harvard University), Joseph H. Antin(Dana-Farber Cancer Institute), Robert J. Soiffer(Dana-Farber Cancer Institute), Edwin P. Alyea(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Siddhartha Jaiswal(Stanford University), R. Coleman Lindsley(Harvard University), Eric D. Jacobsen(Dana-Farber Cancer Institute), Ann S. LaCasce(Otsuka (Japan)), Franziska Michor(Dana-Farber Cancer Institute), David C. Fisher(Dana-Farber Cancer Institute), Sarah Nikiforow(Otsuka (Japan)), Jianbo He(Otsuka (Japan)), Donna Neuberg(Otsuka (Japan))
Cited by 468
Related Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
|Proceedings of the National Academy of Sciences|2005|56.5k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
|New England Journal of Medicine|2014|3.5k